Christopher John Kenney, Chief Medical Officer at Xenon Pharmaceuticals Inc. ($XENE), made one open market sale of company shares in the last year, totaling about $167,000. His most recent sale occurred on March 10, 2026. These sales rank 8,801st among 11,678 individual insiders, far below the average sale amount of $8.6 million across 6.4 transactions. Kenney reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M | Common Shares | 3750 | $0.00 | 8,479.0000 | 79,247,976 | 79.30% | 0.00% |
| March 12, 2026 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M | Restricted Share Units | 3750 | $0.00 | 11,250.0000 | 79,247,976 | 25.00% | 0.00% |
| March 13, 2026 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | S | Common Shares | 1410 | $55.23 | 7,069.0000 | 79,247,976 | 16.63% | 0.00% |
| March 10, 2026 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | S | Common Shares | 2771 | $60.11 | 4,729.0000 | 79,247,976 | 36.95% | 0.00% |
| March 9, 2026 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M | Common Shares | 7500 | $0.00 | 7,500.0000 | 79,247,976 | 9999.99% | 0.01% |
| March 9, 2026 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Performance Share Units | 7500 | $0.00 | 7,500.0000 | 79,247,976 | 9999.99% | 0.01% |
| March 9, 2026 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | M | Performance Share Units | 7500 | $0.00 | 0.0000 | 79,247,976 | 100.00% | 0.01% |
| Jan. 9, 2026 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Restricted Share Units | 20000 | $0.00 | 20,000.0000 | 79,247,976 | 9999.99% | 0.03% |
| Jan. 9, 2026 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Share Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 79,247,976 | 9999.99% | 0.13% |
| March 12, 2025 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Restricted Share Units | 15000 | $0.00 | 15,000.0000 | 77,894,643 | 9999.99% | 0.02% |
| March 12, 2025 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Share Option (Right to Buy) | 80000 | $0.00 | 80,000.0000 | 77,894,643 | 9999.99% | 0.10% |
| March 11, 2024 | Xenon Pharmaceuticals Inc. | $XENE | KENNEY CHRISTOPHER JOHN | Chief Medical Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 66,889,005 | 9999.99% | 0.15% |